Vantas (Endo Pharmaceuticals Solutions Inc.)


Welcome to the PulseAid listing for the Vantas drug offered from Endo Pharmaceuticals Solutions Inc.. This Gonadotropin Releasing Hormone Receptor Agonist [EPC],Gonadotropin Releasing Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.




LABELER NAME / MANUFACTURER: Endo Pharmaceuticals Solutions Inc.
NON-PROPRIETARY NAME: histrelin acetate
SUBSTANCE NAME: HISTRELIN ACETATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Gonadotropin Releasing Hormone Receptor Agonist [EPC],Gonadotropin Releasing Hormone Receptor Agonists [MoA]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: IMPLANT
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2004-11-01
END MARKETING DATE: 0000-00-00


Vantas HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVantas from Endo Pharmaceuticals Solutions Inc.
LABELER NAME: Endo Pharmaceuticals Solutions Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/1)
START MARKETING DATE: 2004-11-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67979-500_1c1df52d-01a3-4b15-a47c-97ac7a524331
PRODUCT NDC: 67979-500
APPLICATION NUMBER: NDA021732

Other HISTRELIN ACETATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Endo Pharmaceuticals Solutions Inc.SUPPRELIN